Attar-hrmt II - R?ge 10 
9312-065 
9312-066 
9312 - 067 * 
9403 - 068 * 
9403-069 
9403-070 
9403-071 
9403-072 
9406-073 
(T/V/C/Melanoma) 
Chang, Alfred E.; University of Michigan, Ann Arbor, Michigan; Adoptive Immunotherapy of 
Melanoma with Activated Lymph Node Cells Primed In Vivo with Autologous Tumor Cells Transduced 
with the IL-4 Gene. 
RAC Approval: 12-3-93/N1H Approval: 8-23-94 
(T/IGD/Cystic Fibrosis) 
Sorscher, Eric J. and Loean, James L.; University of Alabama, Birmineham. Alabama: Gene Therapy 
for Cvstic Fibrosis Usine Cationic Liposome Mediated Gene Transfer: A Phase I Trial of Safety and 
Efficac\- in the Nasal Airway. 
RAC Approval: 12-3-93/NIH Approval: Pending 
(T/IGD/Cystic Fibrosis) 
Welsh, Michael J.; Howard Hughes Medical Institute, Iowa City, Iowa; Adenovirus-Mediated Gene 
Transfer of CFTR to the Nasal Epithelium and Maxillary Sinus of Patients with Cystic Fibrosis. 
RAC Approval: 12-3-93/NIH Approval: 2-10-94 
Minor Modification: 2-17-94 
(T/V/C/Neuroblastoma) 
Rosenblatt, Joseph; University of California, Los Angeles, California; Seeger, Robert, Childrens 
Hospital, Los Angeles, California, and Merritt, James A.; Viagene, Inc., San Diego, California; A 
Phase I Study of Immunization with Qamma Interferon Transduced Neuroblastoma Cells. 
RAC Approval: 3-3-94/N1H Approval: 10-25-94 
Minor Modification: 7-11-94 
Minor Modification: 10-12-94 
(T/HIV) 
Walker, Robert; N1H, Bethesda, Maryland; A Phase I/II Pilot Study of the Safety of the Adoptive 
Transfer of Syngeneic Gene-Modified Cytotoxic T-Lymphocytes in HIV-Infected Identical Twins. 
RAC Approval: 3-3-94/NIH Approval: 8-23-94 
(T/IGD/Alpha-l-Antitrypsin Deficiency) 
Brigham, Kenneth; Vanderbilt University, Nashville, Tennessee; Expression of an Exogenously 
Administered Human Alpha- 1-Antitrypsin Gene in the Respiratory Tract of Humans. 
RAC Approval: 3-3-94/NIH Approval: 10-25-94 
(T/C/Renal Cell) 
Vogelzang, Nicholas; the University of Chicago, Chicago, Illinois; Phase I Study of Immunotherapy 
for Metastatic Renal Cell Carcinoma by Direct Gene Transfer into Metastatic Lesions. 
RAC Approval: 3-4-94/NIH Approval: 4-19-94 
(T/C/Melanoma) 
Hersh, Evan; Arizona Cancer Center, Tuscon, Arizona; and Akporiaye; Harris; Stopeck; Unger; and 
Warneke; the University of Arizona, Tuscon, Arizona; Phase I Study of Immunotherapy of Malignant 
Melanoma by Direct Gene Transfer. 
RAC Approval: 3-4-94/NIH Approval: 4-19-94 
(T/C/Colorectal) 
Curiel, David: University of Alabama. Birmineham. Alabama: Phase I Trial of a Polynucleotide 
Augmented Anti-tumor Immunization to Human Carcinoembrvonic Antitren in Patients with Metastatic 
Colorectal Cancer. 
RAC Approval: 6-9-94/NIH Approval: Pending 
[498] 
Recombinant DNA Research, Volume 20 
